ProKidney Corp. Reports Results for Quarter Ended June 30, 2026

What Happened
ProKidney Corp. (PROK) announced its financial results for the quarter ended June 30, 2026 via a press release dated August 10, 2026. The company furnished that press release as Exhibit 99.1 to a Form 8-K (Item 2.02 — Results of Operations and Financial Condition). The filing was signed by James Coulston, Chief Financial Officer.

Key Details

• Date of filing/announcement: August 10, 2026.
• Period covered: quarter ended June 30, 2026.
• Press release furnished as Exhibit 99.1 to the Form 8-K.
• The company states the 8-K (including the press release) is not "filed" for purposes of Section 18 of the Exchange Act and is not automatically incorporated by reference into other registration statements or filings.

Why It Matters
This Form 8-K notifies investors that ProKidney has publicly released its quarterly earnings/financial results; investors should review the furnished press release for revenue, earnings, guidance or other operational details. Note the legal caveat: the press release is furnished (not "filed") under the Exchange Act, which limits certain incorporation and liability treatments. For audited or comprehensive financial data, investors should consult the press release and any subsequent periodic filings (e.g., 10-Q or 10-K).